What is Haplotype 2? Meaning, Heart Attack Risk, HLA Matching and How to Determine Your Haplotype - healthcare nt sickcare

What is Haplotype 2? Meaning, Heart Attack Risk, HLA Matching and How to Determine Your Haplotype

If you have recently come across the term "Haplotype 2" in the context of a heart attack risk report, a genetic test result, or a news article about hereditary cardiovascular disease, this article explains exactly what it means and what — if anything — you should do about it. If you are searching for "2 haplotype HLA matched" in the context of organ or stem cell transplantation, this article covers that too. The two contexts share the same underlying genetics concept but apply it very differently. A haplotype is a specific combination of genetic variants (alleles or DNA polymorphisms) that are located close together on the same chromosome and are inherited together as a single unit from one parent. Haplotype 2 (H2) most commonly refers to a specific variant of the ABO blood group gene that is associated with elevated levels of Von Willebrand Factor — a blood clotting protein — which increases an individual's lifetime risk of arterial blood clots, heart attack, and stroke. For people in Pune or anywhere in Maharashtra who have been told they carry the Haplotype 2 variant, or who simply want to understand their cardiac risk better, healthcare nt sickcare offers cardiovascular risk blood panels with home sample collection and a direct walk-in facility.

Book VitalCare Health Checkup and Test Packages in Pune

healthcare nt sickcare offers VitalCare health checkup and health monitoring test packages with home sample collection and direct walk-in facility.

What Is Meant by Haplotype? — The Core Concept

A haplotype (from "haploid genotype") is a set of DNA sequence variations — single nucleotide polymorphisms (SNPs), insertions, or deletions — that are found together on a single chromosomal segment and are typically inherited as a block from one biological parent. Because these variants are physically close on the chromosome, they tend to be passed down together rather than being reshuffled by genetic recombination, making them useful as genetic "fingerprints" for ancestry tracing, disease risk profiling, organ matching, and pharmacogenomics. The National Human Genome Research Institute (NHGRI) defines a haplotype as a set of DNA variations that tend to be inherited together as a group.

What Is My Haplotype — How Is It Determined?

Your haplotype at any given genetic locus is determined by your DNA sequence at that chromosomal location, inherited from one parent. Every person has two copies of each chromosome (one from each parent), so every person has two haplotypes at each locus — one maternal and one paternal. How to determine your haplotype requires DNA sequencing or targeted genotyping of the relevant chromosomal region — either a whole-genome test, a whole-exome sequencing panel, or a targeted SNP assay specific to the locus of interest. For clinical purposes — such as ABO Haplotype 2 cardiac risk or HLA haplotype matching for transplantation — targeted genetic assays are used rather than whole-genome sequencing.

How to Count Haplotypes — What Do "1 Haplotype Match" and "2 Haplotype Match" Mean?

In the context of organ transplantation and bone marrow matching, haplotype counting refers to HLA (Human Leukocyte Antigen) compatibility between a donor and recipient. A 2-haplotype HLA match means the donor and recipient share both HLA haplotypes — one inherited from each parent — making them a close or full match at the HLA locus, which significantly reduces the risk of transplant rejection or graft-versus-host disease. A 1-haplotype match means only one of the two parental haplotypes is shared — a partial match, common in non-identical sibling donor pairs. A 0-haplotype match means no shared HLA haplotypes, which carries the highest rejection risk. In practice, full 2-haplotype HLA matching is more reliably found in identical twins, and many successful transplants occur with 1-haplotype or partially matched unrelated donors in combination with immunosuppressive therapy. This HLA matching context is entirely separate from ABO Haplotype 2 and cardiac risk.

Haplotype 2 and Heart Attack Risk — The ABO Connection

In cardiovascular medicine, "Haplotype 2" specifically refers to a variant haplotype of the ABO gene on chromosome 9 that is found in approximately 25% of the general population. Haplotype 2 in the ABO gene context is associated with chronically elevated plasma levels of Von Willebrand Factor (VWF) — a glycoprotein that plays a central role in blood clot formation — which increases the lifetime risk of arterial thrombosis, myocardial infarction, and ischaemic stroke.

What Is Von Willebrand Factor and Why Does Haplotype 2 Raise It?

Von Willebrand Factor (VWF) is a large blood glycoprotein produced primarily by endothelial cells (the cells lining blood vessel walls) and stored in platelets. Its physiological role is critical: when a blood vessel is injured, VWF is released and acts as a bridge that allows platelets to adhere to the damaged vessel wall and form a clot. Without sufficient VWF, bleeding cannot be controlled — which is why severe VWF deficiency causes Von Willebrand disease, a bleeding disorder. Conversely, chronically elevated VWF levels — as seen in Haplotype 2 carriers — shift the clotting balance in the other direction: increasing the tendency for inappropriate clot formation inside intact arteries, particularly in the context of atherosclerotic plaque. Individuals with blood group O naturally have lower VWF levels than those with blood groups A, B, or AB. Within non-O blood groups, those carrying the ABO Haplotype 2 variant have the highest VWF levels of all. Published research in the Journal of Thrombosis and Haemostasis has confirmed that ABO blood group and its associated haplotypes account for approximately 25–30% of the heritable variation in plasma VWF levels — making Haplotype 2 one of the strongest single genetic predictors of thrombotic risk currently identifiable through standard genotyping.

Haplotype 2 Variant and Cardiac Arrest Risk

The Haplotype 2 variant can increase the potential risk of cardiac arrest through a two-step pathway. First, elevated VWF promotes coronary artery clot formation — the immediate cause of a heart attack (myocardial infarction). Second, a severe myocardial infarction that compromises a large area of heart muscle can trigger ventricular arrhythmia — an electrical disturbance in the heart — which can progress to ventricular fibrillation and sudden cardiac arrest. The risk is not absolute: Haplotype 2 is a risk modifier, not a sentence. Other factors — cholesterol levels, blood pressure, blood sugar, smoking, physical activity, and body weight — determine whether the pro-thrombotic tendency actually manifests as an event. Managing those modifiable factors is where preventive diagnostics have the clearest and most immediate impact. Read: the difference between a heart attack and cardiac arrest. Watch: what happens during a heart attack.

Why Are Haplotypes Important for Cardiac Risk in the Indian Population?

Haplotypes are important for cardiac risk because they allow clinicians to identify individuals with a genetically elevated thrombotic tendency — years or decades before a cardiovascular event — enabling targeted preventive monitoring and earlier lifestyle or therapeutic intervention. For the Indian population, this matters particularly because India already carries a disproportionate burden of premature cardiovascular disease. According to the Indian Heart Association, Indians are at a significantly higher risk of heart attacks at younger ages compared to Western populations — with urban Indian men in particular at elevated risk of a first cardiac event before age 50. Understanding genetic risk factors such as Haplotype 2, in combination with modifiable risk markers (LDL cholesterol, HbA1c, homocysteine, and hs-CRP), provides a more complete picture of an individual's actual cardiovascular risk than traditional risk scores alone. Read: testing for diabetes and heart disease.

Regular Tests for People with Haplotype 2 or Elevated Cardiac Risk

If you know you carry the Haplotype 2 variant, or if you have a family history of early heart attack or stroke, the following blood panel provides the most actionable cardiovascular risk picture. These tests are available at healthcare nt sickcare with home sample collection across Pune — Aundh, Baner, Kothrud, Hinjewadi, Viman Nagar, Wakad, Koregaon Park, and Hadapsar — and a direct walk-in facility:

  • Full Lipid Profile — total cholesterol, LDL, HDL, VLDL, and triglycerides. Elevated LDL accelerates atherosclerosis and amplifies the clotting risk mediated by high VWF. Book: lipid profile test. Read: guide to cholesterol testing.
  • hs-CRP (High-Sensitivity C-Reactive Protein) — a marker of low-grade arterial inflammation. Elevated hs-CRP in combination with high LDL and Haplotype 2 represents a convergence of three independent cardiovascular risk pathways. Book: hs-CRP test. Watch: how to test for CRP.
  • Homocysteine — an amino acid that, when elevated, damages endothelial cells lining blood vessel walls — creating the structural conditions that accelerate atherosclerosis and thrombosis. Book: homocysteine test.
  • HbA1c (Glycated Haemoglobin) — diabetes triples cardiovascular risk and significantly worsens outcomes in Haplotype 2 carriers. Book: HbA1c test. Watch: how to test for HbA1c.
  • Coagulation Profile — prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), and fibrinogen levels — to assess overall clotting status in the context of elevated VWF. Book: coagulation profile or blood clotting profile test.
  • Cardiac Risk Markers Profile — a combined panel covering multiple cardiac biomarkers including troponin, NT-proBNP, and others — for comprehensive cardiovascular risk assessment. Book: cardiac risk markers test profile.

For a complete curated panel combining all of the above with a structured annual review, the VitalCare Heart Health Checkup is designed for exactly this purpose. Also available: Smart Choice Heart One and the Healthy Heart test profile. Explore the full cardiovascular health test collection.

Watch: Haplotype 2 and Heart Attack Risk Explained

People Also Ask About Haplotype 2 and Haplotypes

A haplotype is a set of DNA variations that are inherited together as a single block from one parent. Because these genetic variants sit close together on the same chromosome, they tend to be passed down as a unit rather than being separated during reproduction. Every person inherits one haplotype at each genetic locus from their mother and one from their father — giving them two haplotypes per chromosomal region. In medical contexts, haplotypes are used to assess disease risk (such as ABO Haplotype 2 and cardiovascular risk), match donors and recipients in organ transplantation (HLA haplotype matching), and trace ancestry or population history.

Haplotype 2 (H2) is a specific variant of the ABO blood group gene found in approximately 25% of the population. Individuals carrying this variant produce chronically higher levels of Von Willebrand Factor (VWF) — a blood clotting protein — than people with other ABO haplotypes. Elevated VWF increases the tendency for blood clots to form inside arteries, which can block blood supply to the heart and trigger a heart attack (myocardial infarction). Haplotype 2 carriers are estimated to have a 50–80% higher lifetime risk of a cardiac event compared to non-carriers when other risk factors are uncontrolled. However, this risk is significantly modifiable through regular monitoring of cholesterol, blood pressure, blood sugar, and inflammatory markers, alongside a heart-healthy lifestyle.

A 2-haplotype HLA match means that a donor and recipient share both of their HLA (Human Leukocyte Antigen) haplotypes — one inherited from the mother and one from the father. HLA proteins on the surface of cells are what the immune system uses to distinguish "self" from "foreign." In organ and stem cell transplantation, a 2-haplotype HLA match significantly reduces the risk of the recipient's immune system rejecting the donor organ or tissue, or — in bone marrow transplantation — the risk of graft-versus-host disease (GVHD). This context is entirely separate from ABO Haplotype 2 and cardiac risk. The most common scenario for a full 2-haplotype HLA match is between identical twins or, occasionally, between siblings who happened to inherit the same parental HLA haplotypes.

Determining your haplotype requires genetic testing — specifically DNA analysis of the chromosomal region of interest. For ABO Haplotype 2 (cardiac risk context), the relevant test is an ABO genotyping assay that identifies which allele variant you carry at the ABO locus on chromosome 9. For HLA haplotyping (transplant matching context), the test is HLA typing — a specialised molecular test that identifies your HLA-A, HLA-B, HLA-C, HLA-DR, and HLA-DQ alleles. In India, these tests are available through reference genetic laboratories. The karyotyping and genomic testing available at healthcare nt sickcare through NABL-partner reference laboratories covers a range of chromosomal analyses. Consult a geneticist or specialist physician to determine which specific haplotype test is appropriate for your clinical situation.

Haplotypes are important in medicine for three main reasons. First, they help predict disease risk: certain haplotypes are associated with significantly elevated risk of specific conditions — ABO Haplotype 2 and cardiovascular disease is one example; certain HLA haplotypes are associated with autoimmune conditions such as ankylosing spondylitis and type 1 diabetes. Second, they enable transplant matching: HLA haplotype compatibility between donor and recipient determines the probability of transplant success and the likelihood of rejection. Third, they guide pharmacogenomics: specific haplotypes of drug-metabolising enzymes (such as CYP2C19) predict how a patient will respond to medications including antiplatelet drugs — directly relevant for Haplotype 2 carriers being managed for cardiac risk. The field of personalised medicine is built largely on haplotype-based risk stratification and drug selection. Read more: how personalised medicine is becoming mainstream in India.

Yes. While you cannot change your genetic haplotype, the cardiac risk associated with Haplotype 2 is substantially modifiable through regular monitoring and lifestyle management. Research indicates that controlling modifiable risk factors — maintaining optimal LDL cholesterol, blood pressure below 130/80 mmHg, HbA1c below 5.7%, and body weight within a healthy range — can reduce absolute heart attack risk in Haplotype 2 carriers by 30–40% or more. The key is identifying and addressing these modifiable factors early, before arterial damage accumulates. This requires regular blood testing: an annual cardiovascular risk panel covering lipid profile, hs-CRP, homocysteine, HbA1c, and coagulation markers — available at healthcare nt sickcare in Pune with home sample collection. Start with a preventive health check to understand your current baseline and give your physician the data needed to calibrate your personal risk management plan.

healthcare nt sickcare, Pune, Maharashtra, India

Choosing the right pathology laboratory should be simple. Explore reliable blood testing and preventive health check packages designed for Pune residents. Start with a preventive health check to understand your current baseline.

Browse All Lab Tests
Disclaimer

All material copyright healthcare nt sickcare. Terms and Conditions and Privacy Policy apply. The contents of this article are for informational purposes only and do not constitute medical or genetic advice. Information about Haplotype 2, Von Willebrand Factor, and cardiac risk reflects published research in the field as of the date of writing; genetic risk research is evolving and individual clinical implications should be assessed by a qualified physician or genetic counsellor. Cardiac risk estimates cited are population-level statistics and do not predict outcomes for any individual. Always seek the advice of a qualified physician before making decisions based on genetic or diagnostic results. See our full Disclaimer Policy.

© healthcare nt sickcare and healthcarentsickcare.com, 2017–Present. Unauthorised use or duplication without express written permission is strictly prohibited. Excerpts and links may be used provided full and clear credit is given with appropriate direction to the original content. Images in this article are AI-generated using Google Gemini and Shopify Magic.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.